05/11/2026
❤️ELECTROMAGNETIC FREQUENCIES AS A "CLASS 1 THERAPEUTIC AGENT" ❤️
Frequencies commonly associated with healing include 528 Hz for DNA repair and stress reduction, 432 Hz for deep relaxation and improved sleep, and 174 Hz for pain relief. These "Solfeggio frequencies" and tones are often used in meditation music to potentially reduce cortisol, decrease anxiety, and promote, though scientific evidence for specific "miracle" cures is limited.
Not "alternative." Not "complementary." Not "under investigation." Class 1 Therapeutic Agent. The same classification as surgery and pharmaceutical intervention. Equal standing. Full recognition.
The document states the following:
Electromagnetic frequencies between 0.1 Hz and 1000 Hz, when applied at specific amplitudes and durations, produce measurable therapeutic outcomes in:
— Bone regeneration (7.5 Hz pulsed field, 78% acceleration vs. control)
— Chronic pain reduction (10 Hz, 64% reduction in VAS scores)
— Wound healing (15 Hz, 41% faster epithelialization)
— Depression remission (10 Hz alpha entrainment, 52% remission rate vs. 23% SSRI)
— Insomnia resolution (3 Hz delta entrainment, 71% resolution within 21 days)
— Inflammation reduction (30 Hz, CRP decrease of 38% in 14 days)
Six conditions. Six frequency ranges. All outperforming pharmaceutical interventions in controlled trials cited within the document.
⟁
The WHO has known since at least 2019. The document references 340 peer-reviewed studies. 12 meta-analyses. 7 randomized controlled trials funded by WHO member states. The evidence was never in question. The classification was delayed for 7 years.
Why?
Page 51 contains a section titled "Economic Impact Assessment." It estimates that widespread adoption of frequency-based therapeutics would displace approximately $418 billion in annual pharmaceutical revenue across the six indicated conditions.
$418 billion. That is not a typo. That is the number they calculated. That is the number that kept this document internal for 7 years.
Depression alone: $28 billion in SSRI sales per year. A 10 Hz signal from a $200 device achieves higher remission rates. The math is not complicated.